Walgreens Boots Alliance Inc

Marco Green
October 31, 2017

The institutional investor owned 100,394 shares of the pharmacy operator's stock after selling 2,575 shares during the quarter.

WARNING: "Walgreens Boots Alliance, Inc". Hedge funds and other institutional investors own 59.92% of the company's stock. Finally, Modera Wealth Management LLC raised its position in Walgreens Boots Alliance by 0.4% in the first quarter. As of quarter end Raymond James Financial Services Advisors, Inc. had acquired a total of 11,860 shares growing its holdings by 5.0%. Alpha Windward LLC now owns 3,227 shares of the pharmacy operator's stock worth $260,000 after buying an additional 18 shares in the last quarter. Montecito Bank & Trust now owns 6,661 shares of the pharmacy operator's stock valued at $522,000 after acquiring an additional 230 shares during the last quarter. Hanson McClain Inc. raised its position in Walgreens Boots Alliance by 4.6% in the second quarter. During the same quarter previous year, the business posted $1.07 earnings per share. (NASDAQ:WBA) in a research note published on Thursday. Reilly Financial Advisors LLC raised its holdings in shares of Walgreens Boots Alliance by 7.9% in the second quarter. Overall, the share price is down -19.94% so far this year. 6,476,343 shares of the company's stock traded hands. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Walgreens Boots Alliance, Inc. has a 52 week low of $63.82 and a 52 week high of $88.00. Additionally, WBA had a day price range of $64.25 to $66.48.

Moving toward the technical facts, its current distance from 20-Day Simple Moving Average is -8.65% and standing -15.95% away from 50-Day Simple Moving Average while traded down -20.32% from 200-Day Simple Moving Average. Wellington Management Group LLP increased its holdings in Walgreens Boots Alliance by 5.9% in the first quarter.

The P/E ratio is now 16.81 and the market value is 71.23B.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, October 20th. The pharmacy operator reported $1.31 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.21 by $0.10.

Average Revenue Estimate for the current quarter is $29.94 Billion, according to consensus forecast of 16 analysts. The Return on Equity (ROE) value stands at 13.9%. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator's stock valued at $5,480,577,000 after purchasing an additional 1,926,108 shares during the last quarter.

The company reported its EPS on 8/30/2017. The Walgreens Boots Alliance, Inc. has Relative Strength Index (RSI 14) of 33.38 along with Average True Range (ATR 14) of 1.80.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th will be given a dividend of $0.40 per share. The ex-dividend date will be on Wednesday August 16th, 2017. Walgreens Boots Alliance's payout ratio is now 42.33%. The company had Year Ago Sales of 28.5 Billion. The stock was purchased at an average price of $81.41 per share, for a total transaction of $162,820,000.00.

A good way of getting an idea of how institutional investors view the value of a public company's stock is by checking out current active positions.

A number of brokerages recently commented on WBA. They issued an "outperform" rating and a $96.00 price objective on the stock. Deutsche Bank AG reissued a "buy" rating and issued a $94.00 price target on shares of Walgreens Boots Alliance in a research note on Wednesday, September 28th. Hudock Capital Group LLC boosted its stake in shares of Walgreens Boots Alliance by 0.4% in the third quarter. Walgreens Boots Alliance has a consensus rating of "Buy" and a consensus target price of $88.00.

Analysts have given a mean recommendation of 2.40 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). Morgan Stanley reaffirmed an "overweight" rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. The Company is a global pharmacy-led, health and wellbeing enterprise.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER